Study of vision changes in limbal stem cell deficiency
Part of Eyes & vision clinical trials.
This observational study follows patients with limbal stem cell deficiency (a condition affecting cells at the edge of the cornea that help maintain healthy eye surface) to understand how their vision changes over time. Researchers will track your eye health without giving you new treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a diagnosis of limbal stem cell deficiency in at least one eye before enrollment
- Your vision (best corrected) in the study eye is 70 letters or worse on an eye chart at two visits
- Your vision did not change by more than 10 letters between your screening visit and day 1
- You do not have any active eye infection in either eye
- You do not have active inflammation inside the eye (iritis or uveitis) in either eye
- Eye doctors confirm your retina is healthy enough that you could potentially see better
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new eye drop called CSB-001 for people with limbal stem cell deficiency (LSCD), a condition that damages the cornea. The goal is to see if the drops can help improve the health of the cornea and reduce inflammation.
This trial tests an eye treatment made from your own cornea surface cells, grown in a lab and put back into the eye. It may help people with limbal stem cell deficiency by improving the health of the eye surface after a cell biopsy.
This trial tests a treatment that uses your own eye cells to repair the surface of the eye. It may help if you have severe damage to the clear front layer of your eye.
This study looks at how glaucoma and its treatments affect the surface of the eye and proteins in tears. It may help find better ways to manage eye health in people with glaucoma.
This study looks at people with diseases of the eye surface (the clear front part of the eye) to find out which factors predict how well their vision will be after treatment. By joining, you help researchers learn more about these conditions and what may affect visual recovery.
This trial tests an eye drop called BRM421 for people with mild to moderate limbal stem cell deficiency, a condition where the eye's surface doesn't heal properly. The goal is to see if this eye drop helps improve the eye's surface and reduce symptoms.
Hear when a new Limbal Stem Cell Deficiency trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.